Morpholino

MO1-hmcn2

ID

ZDB-MRPHLNO-100528-8

Name

MO1-hmcn2

Previous Names

hmcn2-atg-1 (1)

Target

hmcn2 (1)

Sequence

5' - TAACGACAAACTTTTTCATTCTCAC - 3'

Disclaimer

Although ZFIN verifies reagent sequence data, we recommend that you conduct independent sequence analysis before ordering any reagent.

Note

translation-blocker

Genome Resources

None

Target Location

Genomic Features

No data available

Expression

Gene expression in Wild Types + MO1-hmcn2

Expressed Gene	Anatomy	Figures
hmcn2	(not) vertical myoseptum	Fig. 1 from Martins Feitosa et al., 2012

Phenotype

Phenotype resulting from MO1-hmcn2

No data available

Phenotype of all Fish created by or utilizing MO1-hmcn2

Phenotype	Fish	Conditions	Figures
dermis fibrillar collagen trimer disorganized, abnormal	WT + MO1-fbln1 + MO1-hmcn2	standard conditions	Fig. 3 from Martins Feitosa et al., 2012
trunk dermis malformed, abnormal	WT + MO1-fbln1 + MO1-hmcn2	standard conditions	Fig. 3 from Martins Feitosa et al., 2012
post-vent region integument blistered, abnormal	WT + MO1-fbln1 + MO1-hmcn2	standard conditions	Fig. 2 from Martins Feitosa et al., 2012
trunk integument blistered, abnormal	WT + MO1-fbln1 + MO1-hmcn2	standard conditions	Fig. 2 , Fig. 3 from Martins Feitosa et al., 2012
dermis fibrillar collagen trimer decreased amount, abnormal	WT + MO1-fbln1 + MO1-hmcn2	standard conditions	Fig. 3 from Martins Feitosa et al., 2012
dorsal actinotrichium separated from dorsal fin fold mesenchymal cell, abnormal	WT + MO1-fbln1 + MO1-hmcn2	standard conditions	Fig. 5 from Martins Feitosa et al., 2012
skin morphogenesis decreased process quality, abnormal	WT + MO1-fbln1 + MO1-hmcn2	standard conditions	Fig. 2 , Fig. 3 from Martins Feitosa et al., 2012
dermis separated from epidermis, abnormal	WT + MO1-fbln1 + MO1-hmcn2	standard conditions	Fig. 3 from Martins Feitosa et al., 2012
embryonic medial fin morphogenesis decreased process quality, abnormal	WT + MO1-fbln1 + MO1-hmcn2	standard conditions	Fig. 5 from Martins Feitosa et al., 2012
collagen fibril organization decreased process quality, abnormal	WT + MO1-fbln1 + MO1-hmcn2	standard conditions	Fig. 3 from Martins Feitosa et al., 2012
dorsal fin fold microfibril disorganized, abnormal	WT + MO1-fbln1 + MO1-hmcn2	standard conditions	Fig. 5 from Martins Feitosa et al., 2012
dorsal fin fold mesenchymal cell mislocalised, abnormal	WT + MO1-fbln1 + MO1-hmcn2	standard conditions	Fig. 5 from Martins Feitosa et al., 2012
mesenchymal cell migration decreased process quality, abnormal	WT + MO1-fbln1 + MO1-hmcn2	standard conditions	Fig. 5 from Martins Feitosa et al., 2012
dorsal fin fold dermis malformed, abnormal	WT + MO1-fbln1 + MO1-hmcn2	standard conditions	Fig. 5 from Martins Feitosa et al., 2012
post-vent region integument blistered, abnormal	WT + MO1-hmcn2 + MO3-fbln1 + MO4-fbln1	standard conditions	Fig. 2 from Martins Feitosa et al., 2012
skin morphogenesis decreased process quality, abnormal	WT + MO1-hmcn2 + MO3-fbln1 + MO4-fbln1	standard conditions	Fig. 2 from Martins Feitosa et al., 2012
trunk integument blistered, abnormal	WT + MO1-hmcn2 + MO3-fbln1 + MO4-fbln1	standard conditions	Fig. 2 from Martins Feitosa et al., 2012
median fin fold decreased height, abnormal	sqet37Et + MO1-fbln1 + MO1-hmcn2	standard conditions	Fig. 4 from Martins Feitosa et al., 2012
embryonic medial fin morphogenesis decreased process quality, abnormal	sqet37Et + MO1-fbln1 + MO1-hmcn2	standard conditions	Fig. 4 from Martins Feitosa et al., 2012
median fin fold mesenchymal cell decreased branchiness, abnormal	sqet37Et + MO1-fbln1 + MO1-hmcn2	standard conditions	Fig. 4 from Martins Feitosa et al., 2012
mesenchyme median fin fold mislocalised, abnormal	sqet37Et + MO1-fbln1 + MO1-hmcn2	standard conditions	Fig. 4 from Martins Feitosa et al., 2012
mesenchymal cell migration decreased process quality, abnormal	sqet37Et + MO1-fbln1 + MO1-hmcn2	standard conditions	Fig. 4 from Martins Feitosa et al., 2012

Citations